Glucose Metabolism Disorders

124 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Metabolic Diseases

Narrower: Diabetes Mellitus 94, Diabetes Mellitus, Type 2 72, Glucose Intolerance 2, Hyperglycemia 3, Hypoglycemia 5, Insulin Resistance 21, Metabolic Syndrome 12, Prediabetic State 6

Treatments and conditions

Glucose Metabolism Disorders
Treatment and conditionWhere it standsTrials
AI-Guided Multimodal Rehabilitation Program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Aminohippurate Sodium Inj 20% + CANAGLIFLOZIN for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ARBs in combination of SGLT2i for diabetes mellitusPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ATR-258 for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Avexitide for glucose metabolism disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Avexitide for hypoglycemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
AZD6234 for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Berberine ursodeoxycholate for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Berobenatide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Beta glucan for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for hyperglycemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cagrilintide for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Calorie restricted diet and exercise intervention for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Calorie restriction via total food replacement for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
cfMSC therapy for diabetes for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
cfMSC therapy for diabetes for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CIL001 (Paliroden) for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clofutriben for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Continous Glucose Monitor (CGM) + Low-calorie diet + Personalized exercise program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Control for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Culturally Tailored Diabetes Prevention Program for prediabetic statePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Culturally Tailored Diabetes Prevention Program + Culturally Tailored DPP Enhanced with Socioeconomic Supports for prediabetic statePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Danuglipron for diabetes mellitusPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin + Elecoglipron for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
delayed APM group recruit participants with symptoms lasting for more than 6 months for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dexcom G6 Professional Continuous Glucose Monitor + INSULIN HUMAN for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexcom G6 Professional Continuous Glucose Monitor + Sliding Scale Insulin for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexcom G6 Professional Continuous Glucose Monitor + Up-Titration of Home Insulin for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Diet-as-Usual (DAU) + LCHF Ketogenic Diet for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Digital Intervention + Metformin for prediabetic statePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
digital prosthetic interface technology for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DMR Procedure for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
DMR Procedure (Fractyl) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dulaglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Early arthroscopic partial menisectomy group for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Elecoglipron for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Eloralintide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Eloralintide + Macupatide for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
eloralintide and tirzepatide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Exercise for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Exploratory test group for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ezetimibe or ezetimibe-statin combination therapy for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
fecal microbiota transplantation from healthy lean donors for metabolic syndromeTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Fixed-Dose Combination Strategy for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Food Security Screening & Referral Program for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Food-based diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Formula diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Green coffee + beta-glucan for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Green coffee extract for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HD-6277 100mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HD-6277 25mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HD-6277 50mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity Mediterranean diet intervention for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HS-20094 Injection for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Hyperpolarized 13C-pyruvate for metabolic syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
icovamenib 100 mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
icovamenib 100mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Insulin efsitora alfa for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)12
Insulin efsitora alfa for insulin resistancePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Intensified medical follow-up and glucose-lowering drugs for prediabetic stateTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intensive lifestyle Intervention for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intensive lifestyle Intervention + Meal replacement system for diabetes mellitus, type 2Trials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Intermittent energy restriction (IER) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intermittent fasting 5:2 + Low-carbohydrate diet + Total diet replacement for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
K-757 and K-833 for diabetes mellitus, type 2Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
K-757 and K-833 BID + K-757 and K-833 QD for diabetes mellitus, type 2Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
libitum diet and waiting list control group for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Liraglutide for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-calorie MIND-HK diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Macupatide for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Maridebart Cafraglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Metreleptin for insulin resistancePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MiniMed 670G system for hypoglycemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MKP10241 for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Neovasculgen® for diabetes mellitusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Oral appliance therapy for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)15
Oxytocin for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment. for metabolic syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PF-08653944 for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PG-102 for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine / Topiramate Oral Product for glucose intolerancePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Relacorilant for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Relacorilant for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for diabetes mellitusPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Retatrutide for insulin resistancePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for diabetes mellitusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Semaglutide for glucose intolerancePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for prediabetic statePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Semaglutide + Cagrilintide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Sernova Cell Pouch for hypoglycemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Structured weight-loss program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Survodutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Test group for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tifeglipron for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Time Restricted Eating (TRE) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Time Restricted Eating As Treatment (TREAT) for Diabetes. for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Time restricted feeding for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Time-restricted eating for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for diabetes mellitusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Tirzepatide for metabolic syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Tirzepatide for prediabetic statePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Total Diet Replacement for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Total Diet Replacement (800kcal/day) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Total Diet Replacement (TDR) Program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Very Low-calorie MIND-HK diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vicadrostat for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vitamin D supplementation for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VX-017 for hypoglycemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zenagamtide for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Zimislecel for hypoglycemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.